- Supported exchanges /
- KQ /
- 065660.KQ
Anterogen.Co.Ltd (065660 KQ) stock market data APIs
Anterogen.Co.,Ltd., a bio-venture company, engages in the research, development, and commercialization of stem cell therapy products using adipose-derived stem cells in South Korea and internationally. The company offers medicines, including Cupistem injection, an adipose stem cell product that is used for the treatment of Crohn's fistula; Queencell, a stromal vascular fraction used for the regeneration of subcutaneous adipose tissue; and Remodulin injection, a medicine for the treatment of pulmonary arterial hypertension. It also provides cosmetics, such as hair care products comprising SCM2 and SCM2-Black; and skin care products, such as Therastem-Derma, Therastem-White Silk, and Therastem-White Glutathione, as well as human stem cell conditioned media, a cosmetic raw material. In addition, the company offers cell banking services; and analysis services that include sample analysis for clinical studies, as well as conducts biopharmaceutical tests for identification, purity, potency, adventitious virus, etc. Anterogen.Co.,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea.
Anterogen.Co.Ltd Financial Data Overview
15230 | |
15620 | |
- | |
15770 | |
15080 | |
13020-19150 | |
147 333 M | |
7 954 K | |
7 538 M | |
-16.691 | |
0.4729 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Anterogen.Co.Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 7 538 M
- EBITDA -3 302 020 096
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Anterogen.Co.Ltd Earnings via APIs
- Latest Release 2024-09-30
- EPS/Forecast NaN
Get Anterogen.Co.Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: